Pritelivir met its primary endpoint of superior lesion healing, achieving a 62.7% lesion healing rate compared to 34.0% with ...

Three-phase treatment offers patients with HSV infections an alternative to perpetual antiviral management ROATAN, BAY ...

A phase 3 trial finds pritelivir significantly improves cure rates for immunocompromised individuals with refractory HSV infections.

RTW committed $100M in U.S. launch funding, subject to U.S. Food and Drug Administration (FDA) approval of aglatimagene ...

Citigroup, Cantor, and Stifel are acting as joint bookrunning managers for the offering. LifeSci Capital is acting as lead manager for the offering. H.C. Wainwright & Co. and Brookline Capital Markets ...

The Anti-Corruption Commission on Monday approved a case against eight people, including its former commissioners Md Jahurul ...

Embassy Developments’ project in Alibaug covers approximately 0.2 million sq ft of RERA carpet area, with an estimated GDV of ...

The trial enrolled and treated 101 immunocompromised patients with refractory or resistant HSV infection.

Sustained interest in small molecules, bispecific antibodies, and genomics got the ball rolling in the biotech deals arena in ...

Embassy Developments Ltd has received MahaRERA approval for Phase I of Embassy Serenity in Alibaug, marking its entry into the lifestyle and second-home segment. The 0.2 million square feet project, ...